Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in primary pterygium
NCT05314673Phase 4Completed
- Sponsor
- Fattouma Bourguiba University Hospital
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in pterygium, sponsored by Fattouma Bourguiba University Hospital. Started Jan 2019; status: completed.
02
Drugs
bevacizumab
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT05314673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05314673.